EA200401011A1 - Новые соединения аминокислоты, способ их получения и фармацевтические композиции, содержащие их - Google Patents
Новые соединения аминокислоты, способ их получения и фармацевтические композиции, содержащие ихInfo
- Publication number
- EA200401011A1 EA200401011A1 EA200401011A EA200401011A EA200401011A1 EA 200401011 A1 EA200401011 A1 EA 200401011A1 EA 200401011 A EA200401011 A EA 200401011A EA 200401011 A EA200401011 A EA 200401011A EA 200401011 A1 EA200401011 A1 EA 200401011A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- group
- optionally substituted
- alkyl group
- production
- amino acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
- C07C259/18—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/10—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
- C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
- C07D213/34—Sulfur atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/14—Benz[f]indenes; Hydrogenated benz[f]indenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
- C07C2603/28—Phenalenes; Hydrogenated phenalenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Соединение формулы (I)в которой Rпредставляет собой арильную группу, гетероарильную группу или алкильную группу, необязательно замещённую, или группу формулы -(CO)-CRRNRR, в которой R, R, Rи Rпринимают значения, указанные в описании,Rпредставляет собой атом водорода или алкильную группу,Rпредставляет собой атом водорода или необязательно замещённую алкильную группу,Rпредставляет собой насыщенную или ненасыщенную, семи- - пятнадцатичленную бициклическую систему или необязательно замещённую алкильную группу,или Rи Rвместе с атомом углерода, несущим их, образуют насыщенную или ненасыщенную, трех- - восемнадцатичленную, моно-, би- или трициклическую систему, необязательно содержащую один или больше гетероатомов, выбранных из O, S и N, и необязательно замещённую,n представляет собой 0, 1 или 2,Ar представляет собой арильную или гетероарильную группу,Rпредставляет собой аминогруппу, гуанидиногруппу, цианогруппу и амидиногруппу, которая необязательно замещена,его оптические изомеры, а также его соли присоединения с фармацевтически приемлемой кислотой. Лекарственные средства.Отчет о международном поиске был опубликован 2004.04.08.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0202199A FR2836143B1 (fr) | 2002-02-21 | 2002-02-21 | Nouveaux derives d'acides amines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
PCT/FR2003/000506 WO2003070690A2 (fr) | 2002-02-21 | 2003-02-17 | Nouveaux derives d'acides amines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200401011A1 true EA200401011A1 (ru) | 2004-12-30 |
EA006389B1 EA006389B1 (ru) | 2005-12-29 |
Family
ID=27636380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200401011A EA006389B1 (ru) | 2002-02-21 | 2003-02-17 | Новые соединения аминокислоты, способ их получения и фармацевтические композиции, содержащие их |
Country Status (21)
Country | Link |
---|---|
US (1) | US7265220B2 (ru) |
EP (1) | EP1476421A2 (ru) |
JP (1) | JP4106337B2 (ru) |
KR (1) | KR100668194B1 (ru) |
CN (1) | CN1257889C (ru) |
AR (1) | AR038443A1 (ru) |
AU (1) | AU2003224198A1 (ru) |
BR (1) | BR0307776A (ru) |
CA (1) | CA2474785A1 (ru) |
EA (1) | EA006389B1 (ru) |
FR (1) | FR2836143B1 (ru) |
GE (1) | GEP20074100B (ru) |
HK (1) | HK1079764A1 (ru) |
MA (1) | MA27110A1 (ru) |
MX (1) | MXPA04007988A (ru) |
NO (1) | NO20043910L (ru) |
NZ (1) | NZ534359A (ru) |
PL (1) | PL370817A1 (ru) |
UA (1) | UA77763C2 (ru) |
WO (1) | WO2003070690A2 (ru) |
ZA (1) | ZA200406027B (ru) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7592461B2 (en) * | 2005-12-21 | 2009-09-22 | Bristol-Myers Squibb Company | Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
GB0807828D0 (en) * | 2008-04-29 | 2008-06-04 | Vantia Ltd | Aminopyridine derivatives |
US9290485B2 (en) * | 2010-08-04 | 2016-03-22 | Novartis Ag | N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides |
GB201322091D0 (en) | 2013-12-13 | 2014-01-29 | Cambridge Entpr Ltd | Modified serpins for the treatment of bleeding disorders |
EP3749697A4 (en) | 2018-02-05 | 2021-11-03 | Bio-Rad Laboratories, Inc. | CHROMATOGRAPHIC RESIN WITH A LIGAND WITH ANION EXCHANGE-HYDROPHOBIC MIXED MODE |
CN113195515A (zh) * | 2018-10-29 | 2021-07-30 | 华海美国公司 | 新的二肽类化合物及其用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69406083T2 (de) | 1993-04-28 | 1998-02-26 | Kumiai Chemical Industry Co | Aminosäureamide, bakterizide für gartenbau und landwirtschaft sowie herstellungverfahren |
CA2272095A1 (en) * | 1996-11-19 | 1998-05-28 | Saulius Butenas | Peptidomimetics containing 6-peptidylamino-1-naphthalenesulfonamide moieties |
US6358960B1 (en) * | 1998-02-17 | 2002-03-19 | Ono Pharmaceutical Co., Ltd. | Amidino derivatives and drugs containing the same as the active ingredient |
-
2002
- 2002-02-21 FR FR0202199A patent/FR2836143B1/fr not_active Expired - Fee Related
-
2003
- 2003-02-17 EA EA200401011A patent/EA006389B1/ru not_active IP Right Cessation
- 2003-02-17 WO PCT/FR2003/000506 patent/WO2003070690A2/fr active IP Right Grant
- 2003-02-17 GE GEAP8409A patent/GEP20074100B/en unknown
- 2003-02-17 AU AU2003224198A patent/AU2003224198A1/en not_active Abandoned
- 2003-02-17 US US10/505,005 patent/US7265220B2/en not_active Expired - Fee Related
- 2003-02-17 CA CA002474785A patent/CA2474785A1/fr not_active Abandoned
- 2003-02-17 NZ NZ534359A patent/NZ534359A/en unknown
- 2003-02-17 MX MXPA04007988A patent/MXPA04007988A/es active IP Right Grant
- 2003-02-17 JP JP2003569599A patent/JP4106337B2/ja not_active Expired - Fee Related
- 2003-02-17 KR KR1020047013041A patent/KR100668194B1/ko not_active IP Right Cessation
- 2003-02-17 CN CNB038041189A patent/CN1257889C/zh not_active Expired - Fee Related
- 2003-02-17 UA UA20040907682A patent/UA77763C2/uk unknown
- 2003-02-17 EP EP03720618A patent/EP1476421A2/fr not_active Withdrawn
- 2003-02-17 BR BR0307776-4A patent/BR0307776A/pt not_active IP Right Cessation
- 2003-02-17 PL PL03370817A patent/PL370817A1/xx not_active Application Discontinuation
- 2003-02-21 AR ARP030100563A patent/AR038443A1/es not_active Application Discontinuation
-
2004
- 2004-07-28 ZA ZA200406027A patent/ZA200406027B/en unknown
- 2004-09-20 MA MA27865A patent/MA27110A1/fr unknown
- 2004-09-20 NO NO20043910A patent/NO20043910L/no not_active Application Discontinuation
-
2005
- 2005-12-22 HK HK05111846A patent/HK1079764A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BR0307776A (pt) | 2004-12-07 |
US20050085517A1 (en) | 2005-04-21 |
US7265220B2 (en) | 2007-09-04 |
AR038443A1 (es) | 2005-01-12 |
WO2003070690A2 (fr) | 2003-08-28 |
FR2836143A1 (fr) | 2003-08-22 |
CA2474785A1 (fr) | 2003-08-28 |
NZ534359A (en) | 2005-12-23 |
CN1257889C (zh) | 2006-05-31 |
KR20040085219A (ko) | 2004-10-07 |
EA006389B1 (ru) | 2005-12-29 |
WO2003070690A3 (fr) | 2004-04-08 |
EP1476421A2 (fr) | 2004-11-17 |
NO20043910L (no) | 2004-09-20 |
KR100668194B1 (ko) | 2007-01-11 |
AU2003224198A1 (en) | 2003-09-09 |
MA27110A1 (fr) | 2004-12-20 |
FR2836143B1 (fr) | 2004-04-16 |
HK1079764A1 (en) | 2006-04-13 |
UA77763C2 (en) | 2007-01-15 |
ZA200406027B (en) | 2006-06-28 |
CN1633412A (zh) | 2005-06-29 |
JP2005517734A (ja) | 2005-06-16 |
PL370817A1 (en) | 2005-05-30 |
MXPA04007988A (es) | 2004-11-26 |
JP4106337B2 (ja) | 2008-06-25 |
GEP20074100B (en) | 2007-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2345065C2 (ru) | Ингибиторы протеаз, расщепляющих за пролином | |
EA200401540A1 (ru) | Спироиндолинпиперидиновые производные | |
LU90317I2 (fr) | Tacrolimus et ses sels et dérivés pharmaceutiquement acceptables | |
AR040773A1 (es) | Pirazoles utiles como inhibidores de gsk-3 | |
EA200500312A1 (ru) | Новые спироконденсированные хиназолиноны и их применение в качестве ингибиторов фосфодиэстераз | |
DK1485359T3 (da) | Natriumkanalblokkere | |
RU95101430A (ru) | Производные 1-бифенилметилимидазола, их получение, фармацевтическая композиция, способ лечения или профилактики гипертонии | |
EA200300211A1 (ru) | Азабициклические соединения, способ их получения и их применение в качестве лекарственных средств, в частности в качестве антибактериальных средств | |
EA200200716A1 (ru) | Арилконденсированные азаполициклические соединения | |
RU92016217A (ru) | Двойные ингибиторы no синтазы и циклооксигеназы, способ их получения и фармацевтическая композиция на их основе | |
NO985864L (no) | Nye anti-virale forbindelser | |
RU94028888A (ru) | Производные 1,3-замещенного циклоалкана и циклоалкена, смесь их изомеров или индивидуальные изомеры, их гидраты и соли, способ их получения и фармацевтическая композиция | |
EA200401053A1 (ru) | Оксо-азабициклические соединения | |
EA199800794A1 (ru) | Новые производные арилглициламида, способ их получения и фармацевтическая композиция, содержащая эти соединения | |
EA200100994A1 (ru) | 1-АМИНОТРИАЗОЛО[4,3-а]ХИНАЗОЛИН-5-ОНЫ И/ИЛИ -5-ТИОНЫ, ИНГИБИРУЮЩИЕ ФОСФОДИЭСТЕРАЗУ-IV | |
EA200201264A1 (ru) | 5-хлор-3(4-метансульфонилфенил)-6'-метил-[2,3']бипиридинил в чистой кристаллической форме и способ синтеза | |
Jung et al. | Stereoselective synthesis of vicinal diamines from alkenes and cyanamide | |
EA200400129A1 (ru) | Способ получения периндоприла, его аналогов и солей с использованием 2,5-диоксооксазолидиновых промежуточных соединений | |
EA200000792A2 (ru) | Новые пиридиновые соединения, способ их получения и содержащие их фармацевтические композиции | |
RU94046107A (ru) | Замещенные производные 2 бета - морфолинандростана, способ их получения, фармакомпозиция, содержащая их | |
EA200500690A1 (ru) | Новые соединения пиридопиримидинона, способ их получения и фармацевтические композиции, которые их содержат | |
EA200500683A1 (ru) | Новые соединения пирролидина и тиазолидина, способ их получения и фармацевтические композиции, которые их содержат | |
EA200401011A1 (ru) | Новые соединения аминокислоты, способ их получения и фармацевтические композиции, содержащие их | |
EA200100969A1 (ru) | Новые соединения циклобутендиона, способ их получения и содержащие их фармацевтические композиции | |
EA200300272A1 (ru) | Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |